Currently, ten percent of Americans age 65 and older suffer from Alzheimer’s disease. That adds up to over five million people already diagnosed, while the at-risk population continues to grow rapidly. Without intervention, this chronic neurodegenerative brain disorder is predicted to impact sixteen million people in this country by 2050. At this time, there is no known cure for Alzheimer’s disease. Treatment has largely been focused on controlling the symptoms. Unfortunately, the commonly prescribed medications result in numerous adverse side effects, including nausea, vomiting, indigestions, reduced appetite, chest pain and cramps. Some of the long-term complications include convulsions, stroke, heart, liver and kidney problems. There is some good news. Recent studies show that elements found in the cannabis sativa plant are helpful in the treatment of Alzheimer’s disease, Parkinson’s and HIV dementia. Cannabinoids have the capability to remove the buildup of senile plaques and inhibit the inflammatory process that speeds the progression of Alzheimer’s disease. In a four-week study, ten patients afflicted with Alzheimer’s disease were given cannabis oil. Results indicated a significant decrease in delusions, agitations, irritability, apathy, sleep and caregiver distress. A study performed on mice with advanced Alzheimer’s disease demonstrated that a combination of THC and CBD decreased memory impairment. Research continues, but success stories offer new hope for patients and their family members. People can now take advantage of a natural remedy that causes no adverse side-effects and is far less costly than conventional medications. With the legalization of of medical marijuana, more and more people are getting the help they need. Plus, this safe and effective treatment gains offers potential for preventative measures.